Novel Coronavirus (SARS-CoV-2/COVID-19)
Regeneron Pharmaceuticals Inc. announced interim data indicating that its REGEN-COV antibody cocktail could be used as a passive vaccine to prevent COVID-19.
This year, I look forward to continuing AHA鈥檚 Leadership Rounds, short conversations on trending topics with health care leaders from around the country.
America鈥檚 hospitals and health systems have faced unprecedented financial pressures due to the COVID-19 pandemic.
As COVID-19 surges continue, lessons learned by health systems large and small reveal the importance of teamwork, communication, flexibility, preparation and supporting the physical and mental health of all staff.
The Centers for Disease Control and Prevention reported 10 cases of anaphylaxis, a life-threatening allergic reaction, among the more than 4 million people who received a first dose of the Moderna COVID-19 vaccine between Dec. 21, 2020, and Jan. 10, 2021.
Full-dose blood thinner treatments can reduce the need for vital organ support such as ventilation in moderately ill patients hospitalized for COVID-19, according to interim results from a clinical trial announced by the National Institutes of Health.
The novel coronavirus global pandemic upended hospital laboratories when it first emerged.
鈥淲e have much to do, much to repair, much to restore, much to heal, much to build 鈥 and much to gain.鈥
President Biden today took a number of actions, including signing a series of executive orders (EOs), aimed at addressing the COVID-19 pandemic.
AHA statement from President and CEO Rick Pollack on President Biden鈥檚 Executive Orders.